Short Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Declines By 32.7%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 7,600 shares, a drop of 32.7% from the August 15th total of 11,300 shares. Based on an average daily volume of 104,100 shares, the short-interest ratio is presently 0.1 days.

Ono Pharmaceutical Price Performance

Shares of OTCMKTS:OPHLY traded up $0.02 during trading on Monday, reaching $4.45. 211,624 shares of the company’s stock traded hands, compared to its average volume of 131,307. Ono Pharmaceutical has a fifty-two week low of $4.32 and a fifty-two week high of $6.69. The company has a 50-day simple moving average of $4.77 and a 200-day simple moving average of $4.90.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.